Abbvie (ABBV) PT Lowered to $80 at Piper Jaffray
Tweet
Share
E-mail
Get Alerts ABBV Hot Sheet
Price: $234.76 +2.07%
Rating Summary:
26 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 14 | New: 26
Rating Summary:
26 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 14 | New: 26
Join SI Premium – FREE
Piper Jaffray analyst Christopher Raymond lowered the price target on Abbvie (NYSE: ABBV) to $80.00 (from $90.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Abbvie (ABBV) PT Raised to $273 at Canaccord
- EU approves AbbVie's Maviret for acute hepatitis C treatment
- Natera (NTRA) PT Raised to $270 at BTIG
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
